| Total Revenue | | 0 | 0 | 0 | |
| Cost of Goods Sold Incl. D&A | | 3 | 0 | 4 |
| Gross Profit | | -3 | 0 | -4 |
| Selling, General and Administrative Excl. Other | | 39 | 42 | 38 |
| Research and Development | | 93 | 115 | 104 |
| Other Operating Expense | | -4 | 23 | -4 |
| Operating Income | | -131 | -180 | -142 |
| Interest Expense | | 0 | 0 | 0 |
| Unusual Expense | | — | — | — |
| Non-Operating Income (Expense) | | -7 | -22 | -16 |
| Net Income Before Taxes | | -125 | -162 | -125 |
| Income Taxes | | 0 | 0 | 0 |
| Consolidated Net Income | | -125 | -162 | -125 |
| Net Income From Continuing Operations | | -125 | -162 | -125 |
| Net Income | | -125 | -162 | -125 |
| EPS (Recurring) | | -0.44 | -0.69 | -0.83 |
| EPS (Basic, Before Extraordinaries) | | -0.44 | -0.69 | -0.83 |
| EPS (Diluted) | | -0.44 | -0.69 | -0.83 |
| EBITDA | | -121 | -153 | -121 |
| Other After Tax Adjustments | | — | — | — |
| Stock Option Compensation Expense | | — | — | — |
| Price To Earnings Ratio | | — | — | — |
| Price To Sales Ratio | | — | — | — |
| Gross Margin | | — | — | — |
| Operating Margin | | — | — | — |
| Net Margin | | — | — | — |
| Shares Outstanding | | 284 | 234 | 150 |
| Market Capitalization | | 1,056 | — | — |
| Operating Lease Expense | | — | — | — |
